Essential HTN in adults, children & adolescents 6–18 yr. Renal disease in adults with HTN & type 2 DM with proteinuria ≥0.5 g daily as part of an antihypertensive treatment. Chronic heart failure in adults when treatment with ACE inhibitors is not considered suitable. Reduction in risk of stroke in adult hypertensive patients with left ventricular hypertrophy documented by ECG.

This is not a substitute for consulting your doctor. Seek professional advice if you are experiencing any illness or symptoms.

HTN Initial & maintenance dose: 50 mg once daily, may be increased to 100 mg once daily for additional benefit in some patients. Hypertensive type II diabetic patient with proteinuria ≥ 0.5 g daily Initially 50 mg once daily, may be increased to 100 mg once daily based on BP response from 1 month onwards after initiation of therapy. Heart failure Initially 12.5 mg once daily, titrated at weekly intervals (i.e., 12.5 mg daily, 25 mg daily, 50 mg daily, 100 mg daily, up to a max: 150 mg once daily) as tolerated. Reduction in risk of stroke in hypertensive patient with left ventricular hypertrophy documented by ECG Initially 50 mg once daily, increased to 100 mg once daily & added with a low dose hydrochlorothiazide. Patient with intravascular volume depletion Initially 25 mg once daily. Patient >50 kg 50 mg once daily, can be adjusted to max of 100 mg once daily in exceptional cases. >20 to <50 kg 25 mg once daily, can be increased to max of 50 mg once daily in exceptional cases.

Maybe taken with or without food.